A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C

Clinical trial NCT06165250 · COMPLETED

Trial details

NCT number: NCT06165250
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension Primary Hypercholesterolemia

Start date: 2024-04-17
Primary completion: 2025-11-11
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.